With RNA sequencing, more researchers are using transcriptomics to advance drug development and ultimately improve human health
An academic medical center brings WGS in-house and reaps the benefits of faster turnaround times, reduced complexity, and expanded results
One genetic test changed everything for her son. Now Bliss, the founder of Start Genetic, wants more families to get answers sooner.
Across China, Illumina is delivering end-to-end research analysis support, scalable high-performance computing, and localized deployment
How CEO Jacob Thaysen’s journey was shaped by a drive to transform health—and how Illumina is redefining genomics workflows
| Date | Publication | Title |
|---|---|---|
| 23 Jun. 2025 | Endpoints News | Illumina to buy SomaLogic for $350M upfront, pushing further into proteomics |
| 17 Jun. 2025 | Forbes | Illumina’s New CIO Brings R&D Mindset As AI Transforms Genomics |
| 13 Jun. 2025 | GEN | Proteomics Partnerships Move Multiomics from Theory to Practice |
| 13 Jun. 2025 | GEN | Silver Anniversary of the Human Genome Project |
| 12 Jun. 2025 | Colorado State University | The pathogen hunter: Next-Generation Sequencing tracks down genetic mutations |
At Illumina, we push boundaries. We think beyond the conventional. We dream big. With the energy of so many bright and accomplished people, the opportunities are endless.
Search for JobsIf you are a member of the media:
If you are not a member of the media, please visit Contact Us.